January 8, 2025 - 13:08

Kelly Loeffler has often portrayed herself as a quintessential entrepreneur, claiming that her strong work ethic allowed her to rise from humble beginnings on a family farm to prominent roles in finance and politics. However, a deeper examination reveals a more nuanced reality regarding her entrepreneurial ventures.
Loeffler’s tenure as a small business owner has been marred by challenges that raise questions about her effectiveness in that role. Reports indicate that her business faced significant hurdles, including financial difficulties that ultimately led to its closure. This experience contrasts sharply with her narrative of success and resilience, suggesting that her journey may not be as straightforward as she claims.
As Loeffler seeks to position herself as a champion for small businesses, her past raises critical questions about her qualifications and experience. The complexities of her entrepreneurial history highlight the gap between perception and reality, prompting scrutiny of her ability to advocate effectively for small business owners in her potential role within the Small Business Administration.
May 16, 2026 - 00:10
Blake's Snow Shack owned by man with Down syndrome in Texas turns 10In the small North Texas town of Sanger, a beloved local business is marking a sweet anniversary. Blake`s Snow Shack, a shaved ice stand owned and operated by a man with Down syndrome, is turning...
May 15, 2026 - 04:31
SBA Launches Small Business Pitch Competition » CBIAThe U.S. Small Business Administration has announced a new pitch competition aimed at companies that show strong innovation and have a track record of using SBA-backed financing tools. The contest...
May 14, 2026 - 01:02
INOVIO Reports First Quarter 2026 Financial Results and Recent Business HighlightsINOVIO has released its financial results for the first quarter of 2026, alongside a summary of recent business developments. The company`s primary focus remains on the regulatory path for its lead...
May 13, 2026 - 04:15
Curis Provides First Quarter 2026 Business UpdateCuris, Inc., a biotechnology company advancing the development of its lead drug candidate emavusertib, provided a business update for the first quarter of 2026. The company is focused on...